When miniscrew-assisted expansion underperforms, the post-treatment CBCT reveals exactly why. Learn the evidence-based framework for identifying skeletal response, dental tipping, miniscrew stability, and compliance errors—then decide whether to modify, re-treat, or escalate to surgical expansion.
TL;DR MARPE failure analysis requires systematic CBCT evaluation of midpalatal suture separation, skeletal versus dental contribution ratio, and miniscrew stability. Reverse-engineering the final radiograph reveals whether expansion failed due to inadequate skeletal response, excessive dental tipping, miniscrew displacement, or protocol non-compliance. This retrospective approach guides case modification and future appliance selection.
When a MARPE case does not deliver expected skeletal expansion, the final CBCT holds critical diagnostic clues. Reverse-engineering a miniscrew-assisted rapid palatal expansion failure from the final radiograph requires systematic analysis of suture separation patterns, skeletal versus dentoalveolar contribution, miniscrew position, and alveolar bone response. At Orthodontist Mark, we combine CBCT morphometrics with clinical protocol review to identify whether failure stems from biomechanical error, patient compliance, anatomical limitation, or appliance design mismatch. This evidence-based framework transforms a disappointing outcome into actionable intelligence for case rescue and future patient selection.
MARPE failure analysis begins with understanding what the final CBCT should—and should not—show. A systematic radiographic assessment compares actual skeletal response to expected response for the amount of screw activation and treatment duration. The primary measurement is midpalatal suture separation at the anterior nasal spine, mid-palate, and posterior nasal spine. In successful cases, suture opening exceeds dental movement. In failures, the reverse occurs. The next critical parameter is total maxillary width at the canine, premolar, and molar regions, subdivided into skeletal contribution (true palatal width increase) and dental contribution (buccal tipping of anchor teeth). Miniscrew position stability is evaluated by superimposing pre-treatment and post-treatment axial slices at the level of miniscrew insertion. Displacement of >1–2 mm indicates load failure or bone resorption.
A retrospective CBCT failure analysis also assesses alveolar bone bending and thickness on the buccal aspect of maxillary molars and premolars. In hybrid tooth-bone expanders like the MSE, some buccal bone loss is expected. In bone-borne systems, it should be minimal. Excessive buccal tipping—measured as the angulation change of posterior tooth roots relative to the palatal midline—is a red flag for inadequate anchorage or premature miniscrew loosening. The nasal floor angle and nasal width at the pyriform aperture are also assessed. Patients with rigid lateral nasal walls or thick buccal cortices may show restricted skeletal response despite adequate suture separation. Finally, evaluate the pattern of suture opening: parallel opening in the axial plane is favorable, whereas asymmetrical or hinged opening suggests unequal miniscrew load distribution.
Clinically, these measurements are placed in the context of patient age, skeletal maturity (cervical vertebral stage), initial transverse maxillary deficiency severity, and treatment duration. A 13-year-old with patent sutures who received 8 weeks of expansion and shows minimal skeletal gain raises suspicion of compliance failure or miniscrew loosening. The same radiographic pattern in a 28-year-old suggests true skeletal resistance and possible need for SARPE. This contextualization transforms raw CBCT data into differential diagnosis.
One of the most common MARPE failure patterns is apparent expansion with minimal skeletal gain—what clinicians often misinterpret as success. The final CBCT shows wide premolar and molar arches, open bite, and suture separation. Yet cross-sectional measurements reveal that 80–90% of the apparent width increase came from dental buccal tipping rather than true palatal skeletal expansion. This occurs when miniscrews loosen early, reducing skeletal load and permitting teeth to flare outward. The distinction is critical: dental flare is unstable, relapse-prone, and carries periodontal risk. True skeletal expansion, by contrast, is stable and provides a lasting platform for arch coordination.
The research literature defines successful skeletal expansion as skeletal contribution ≥50–60% of total width gain. A prospective comparative study reported that bone-anchored maxillary expanders (BAME) achieved 83% skeletal contribution versus 56% for hybrid tooth-bone expanders (MSE), and significantly less dental tipping in the BAME cohort. When your CBCT reveals a 4.7 mm total width gain at the molars but only 1.2 mm of true palatal width increase—the rest being dental flare—you are facing a dentoalveolar, not skeletal, outcome. The clinical implication: retreat or accept limited gain and rely on fixed appliance coordination.
To assess skeletal versus dental contribution on CBCT, measure palatal width at the level of the cemento-enamel junction (CEJ) of the maxillary molars in both axial and coronal planes. This isolates skeletal change. Compare to the width at the buccal alveolar crest. The difference indicates alveolar bone bending and tooth tipping. Miniscrew displacement is the most common culprit for low skeletal contribution: if either miniscrew has migrated occlusally or palatally by >2 mm, load was not sustained, and the expansion defaulted to dental movement. This reverse-engineering step is essential before deciding whether to re-treat or accept the outcome.
Miniscrew displacement is the primary cause of MARPE expansion failure and the most overlooked finding on final CBCT. Superimpose the pre-treatment and post-treatment axial CBCT slices at the level of miniscrew insertion and measure the center-to-center distance of each screw. Displacement of 1–2 mm palatally or occlusally, even if subtle clinically, correlates with load loss and early termination of skeletal response. In failed cases, you may find 2–3 mm displacement, indicating the miniscrew bore no load during the final phase of expansion—all remaining movement was dental.
The mechanism of miniscrew loosening in MARPE is multifactorial. Cortical bone resorption around the apical region of the miniscrew occurs within the first 4–6 weeks if cortical density is suboptimal. Patients with dense medullary bone but thin palatal cortex (Hounsfield unit assessment on CBCT reveals this) are at high risk. Additionally, miniscrews inserted between posterior roots are vulnerable to root contact stress. A miniscrew impinging on the distal root of a maxillary molar creates shear loading during expansion activation and accelerates bone resorption. The final radiograph may show a radiolucency around the miniscrew apical third—this is bone loss, not artifact.
Clinically, MARPE failure owing to miniscrew loosening presents as a plateau in maxillary width gain around weeks 4–6, inability to achieve designed activation turns, and increasing patient-reported movement or clicking at the miniscrew. On CBCT, cross-reference the miniscrew position with the anatomy of adjacent teeth: if the miniscrew is within 1–2 mm of a molar root or within the periosteal layer, it was always at risk. For future cases, this finding informs miniscrew placement depth, angulation, and location—move more anteriorly to thicker cortex, or select bone-borne anchors if palatal anatomy is marginal. Documentation of miniscrew stability (or lack thereof) transforms a failed case into a protocol refinement.
The alveolar bone surrounding the posterior maxilla tells a detailed story about the quality and sustainability of MARPE expansion. On axial and coronal CBCT views, measure buccal alveolar bone thickness at the level of the maxillary molar buccal roots in both pre-treatment and post-expansion images. Successful skeletal expansion typically results in 0–2 mm of buccal bone loss and visible buccal cortical bending (outward curvature of the buccal plate as the palate widens). Excessive buccal bone loss—3 mm or more—indicates high dental tipping, suboptimal load distribution, or excessive expansion force relative to bone biological response.
The nasal floor and lateral nasal wall also provide insight into skeletal resistance. In patients with a thick, rigid lateral nasal wall (common in individuals of African or Asian ancestry, or in older adults with advanced skeletal maturation), the nasal floor angle widens minimally despite substantial palatal separation. This is not failure of the MARPE. It is normal anatomical response to a rigid nasal structure. However, it explains why some patients with good suture separation show limited functional nasal width gain. Conversely, absence of nasal floor widening in a young patient with patent sutures is a red flag for miniscrew displacement or inadequate load.
Buccal cortical resorption is distinguished from bone bending on CBCT by observing the periosteal outline: inward migration of the cortical surface indicates resorption. Outward curvature without surface loss indicates bending. In hybrid expanders, some buccal cortical resorption is expected owing to dental flare. In bone-borne systems, it should be absent or minimal. If your CBCT shows marked cortical resorption, denude the buccal aspect of the miniscrew insertion area, or miniscrews were loaded at an angle. Periodontal complications—gingival recession, attachment loss, or pocket deepening on molars and premolars—may accompany buccal cortical resorption. This finding on CBCT warrants post-treatment periodontal assessment and possible scaling or grafting.
A systematic MARPE failure analysis always includes a review of clinical notes and activation records against the radiographic outcome. Calculate the expected total expansion based on documented turns per day, number of days activated, and screw pitch (typically 0.2 mm per quarter-turn, or 0.8 mm per full turn). Then measure actual total width gain on CBCT. Discrepancies reveal compliance failure. For example, if protocol called for 4 turns daily for 56 days (224 turns, ~18 mm expected expansion) but actual molar width gain is only 8 mm, the patient or clinician did not execute the plan.
Common compliance failures include: (1) patient cessation of activation after week 4, believing expansion was complete; (2) clinician failure to reactivate the screw during scheduled office visits; (3) unequal bilateral miniscrew loading owing to uneven turn distribution. And (4) interruption of expansion due to miniscrew loosening, after which activation was halted rather than miniscrews replaced. The final CBCT cannot distinguish these scenarios directly, but cross-referencing radiographs with clinical notes reveals the pattern. A patient whose activation records show regular turns for 8 weeks but whose CBCT shows minimal skeletal response has true biological resistance. A patient with spotty activation records and minimal CBCT gain has a compliance or load-distribution problem.
Additionally, evaluate whether screw activation was symmetrical. If miniscrew-assisted rapid palatal expansion records document more turns on one side, the post-expansion CBCT should show asymmetrical suture opening and unequal molar width gain. Symmetrical suture opening with asymmetrical clinical effect suggests unequal miniscrew engagement or early loosening on one side. These findings guide patient education for future cases and inform whether re-treatment should focus on reinitiation with compliance reinforcement or referral for SARPE. Documentation of this analysis in the chart protects against liability and demonstrates thorough case review.
The type of expansion appliance selected—miniscrew-assisted rapid palatal expansion (MARPE/MSE hybrid), bone-anchored maxillary expander (BAME), or surgical assisted rapid palatal expansion (SARPE)—directly influences the CBCT failure pattern. A hybrid tooth-bone expander like the MSE is designed to achieve 50–60% skeletal contribution and accepts some dental flare as inherent to the biomechanical design. If your final CBCT shows 4.5 mm total width gain with 2.5 mm skeletal contribution (56%) and modest dental tipping, the MSE performed as designed—no failure. Conversely, if the same appliance shows only 1.5 mm skeletal contribution (33%), miniscrew loosening or inadequate load is the culprit.
Pure bone-borne systems (BAME, bone-only anchors) are engineered to maximize skeletal response and minimize dental side effects. Failure patterns in BAME cases differ: poor outcomes typically reflect inadequate bone quality at the miniscrew site (insufficient cortical thickness), rather than inherent appliance limitation. If a BAME case shows <70% skeletal contribution, the issue is bone—consider SARPE for the next attempt in that patient. Hybrid systems used in patients with very dense skeletal patterns or severely restricted transverse maxillary deficiency may show unexpected resistance; in these cohorts, SARPE from the outset avoids the trial-and-error of MARPE failure.
CBCT analysis of a failed MARPE or BAME case informs whether re-treatment with the same system, modification of protocol (increased activation duration, different load magnitude), or escalation to SARPE is appropriate. A 16-year-old with patent sutures whose CBCT shows adequate miniscrew stability, decent bone quality, and minimal suture separation despite 8 weeks of activation suggests true skeletal resistance and early SARPE consultation. A 15-year-old with loosened miniscrews and buccal bone loss may benefit from miniscrew replacement and continued expansion. Document the appliance type and design logic in your failure analysis. This contextualizes the CBCT findings and justifies the next clinical decision.
Once you have systematically analyzed the CBCT, you face a clinical decision: modify and re-treat, document as achieved and proceed to fixed appliance coordination, or refer for SARPE. The decision hinges on three factors identified in your CBCT analysis. (1) Skeletal maturity and suture patency: if the patient is <18 years old and sutures are clearly patent (broad, radiolucent lines in the axial plane), re-treatment with modified protocol is justified. If the patient is >25 years old and sutures are fused or partially fused, SARPE is indicated for >70% of the remaining deficiency. (2) Miniscrew stability and bone quality: if miniscrews were stable and bone appeared adequate, repeat MARPE with increased duration (10–12 weeks instead of 8) or slightly higher activation rate (3.5 turns daily instead of 3) may succeed. If miniscrews loosened, assess whether palatal cortical thickness permits reinsertion at the same location. If not, move to a more anterior location with thicker cortex, or escalate to SARPE. (3) Magnitude of skeletal deficiency still present: if the CBCT shows that you achieved 6 mm of the needed 9 mm expansion, partial retreat with modified protocol may be cost-effective and patient-acceptable. If you achieved 3 mm of 10 mm needed, SARPE avoids prolonged MARPE frustration.
The retreatment protocol for a failed MARPE case typically includes: confirmation of miniscrew stability by intraoral exam and selective CBCT. Selective removal of the appliance. Reassessment of miniscrew engagement by testing for play. Reinitiation of gentle expansion at a slightly lower activation rate (2.5–3 turns daily) over 10–12 weeks if miniscrews are solid, or miniscrew replacement if loosening is evident. Patients must understand that retreatment carries risk of reduced response. Set expectations realistically. Periodically re-image (8-week interim CBCT) to confirm skeletal gain is resuming. If a second attempt yields similarly poor results, refer for SARPE without further delay.
Documentation of the failure analysis, attempted interventions, and rationale for the next step is essential for medicolegal protection and for your own learning. Maintain a clinical database of MARPE cases with outcome codes (successful, partial failure with modification, failure with SARPE referral). Over time, this data reveals your patient selection strengths, technique vulnerabilities, and protocol refinements. Dr. Mark Radzhabov advocates logging CBCT measurements for each case—suture opening, skeletal contribution percentage, miniscrew displacement, alveolar bone loss—and correlating these with appliance type, patient age, and treatment duration. This systematic approach transforms individual failures into practice-wide quality improvement.
Fundamental course covering CBCT patient selection, miniscrew planning, activation protocols, and 60+ clinical cases. Choose the access level that fits your practice.
Essentials of rapid palatal expansion for practicing orthodontists.
Deep-dive into MARPE protocol, diagnostics, and clinical execution.
5-element medical consultation framework for dentists and orthodontists.
Begin with midpalatal suture separation at three levels: anterior nasal spine, mid-palate, and posterior nasal spine. Sutures opening in <50% of cases suggests inadequate load or miniscrew loosening. Parallel versus hinged opening patterns also indicate load symmetry.
Measure palatal width at the CEJ level of maxillary molars (skeletal component) and alveolar crest width (total expansion). Subtract skeletal gain from total gain to obtain dental contribution. Skeletal percentage >50% is satisfactory for hybrid expanders, >70% for bone-borne systems.
Superimpose pre- and post-expansion axial slices at miniscrew insertion. Displacement >1–2 mm, radiolucency around apical miniscrew region, or off-axis orientation suggests bone resorption and load loss. Confirm clinically by testing screw stability with explorer.
Yes. Buccal cortical resorption >2–3 mm correlates with dental flare and higher relapse risk. Bone bending without surface loss is favorable. Bone loss indicates excessive tipping or suboptimal load distribution.
Compare suture separation quality (patent, wide, or fused), miniscrew position stability (displaced or centered), and alveolar bone bending (present or absent). Wide patent sutures with stable miniscrews but minimal bone bending suggest true resistance. Loose miniscrews with buccal flare indicate load failure.
MARPE hybrid expanders (MSE) typically achieve 50–60% skeletal contribution. Bone-borne systems (BAME) achieve 70–85%. If your hybrid system shows <50% skeletal gain, miniscrew or load distribution is the issue, not design.
Refer for SARPE if patient age >25 with fused sutures, miniscrew replacement is not anatomically feasible, or two sequential MARPE attempts yield <50% expected skeletal gain. Young patients with patent sutures and stable miniscrews may justify one extended retreatment.
Calculate expected expansion from activation records (turns × days × 0.2 mm per quarter-turn). If CBCT gain is <50% of expected, review notes for gaps in activation. Symmetric suture opening with asymmetric clinical effect suggests unequal miniscrew loading.
Asymmetrical suture separation (wider on one side) indicates unequal miniscrew load distribution or early loosening on the narrower side. Confirms need to rebalance activation or assess miniscrew stability bilaterally.
Record three sections: (1) skeletal measurements with percentages, (2) miniscrew stability assessment with displacement values, (3) decision rationale (retreat vs. SARPE vs. accept and proceed). This systematizes learning and protects against liability.
Retrospective MARPE failure analysis is not about assigning blame—it is about extracting diagnostic value from the final radiograph to prevent recurrence. By systematically evaluating midpalatal suture opening, skeletal gain, dental side effects, and miniscrew stability on CBCT, you can pinpoint the root cause and decide whether to re-treat with modified protocol, convert to SARPE, or document the learning for your next case. Dr. Mark Radzhabov advocates for this structured review process as essential to mastering skeletal expansion. Visit ortodontmark.com to submit challenging cases for detailed CBCT analysis or enroll in the MARPE mastery course to refine your diagnostic eye.